EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudie

A critical comparison of pharmacovigilance reporting forms in six countries with the WHO-UMC recommendations (form of the form)

Saurav Misra, Manmeet Kaur, Jayant Kumar Kairi

Journal of Basic and Clinical Physiology and Pharmacology · 2025

DOI: 10.1515/jbcpp-2025-0084 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, 2025. Verfasst von Saurav Misra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Kalpana Chawla Government Medical College, Karnal, India. Hauptthemen laut MEDLINE: Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study will identify strengths and weaknesses of ADR reporting forms of study countries.

Methods

This was an observational study conducted at the Department of Pharmacology at Kalpana Chawla Government Medical College, Karnal. We obtained the WHO-UMC adverse event reporting guidance document for designing the ADR form for member countries. We similarly collected and analysed ADR forms from Australia, Canada, India, South Africa, the UK, and the US. Data fields were grouped into different subgroups.

Results

An analysis of ADR reporting forms from six countries revealed a total of 70 data fields. The US-FDA’s FORM 3500 has the most fields at 50 (71 %), followed by India’s CDSCO with 42 fields (60 %). According to WHO-UMC recommendations, Canada and Australia have the highest number of suggested fields at 10 (83 %). All forms were one page long except for the US-FDA’s, which is five pages.

Conclusions

Improving patient feedback and organisational engagement is essential to raise awareness of the reporting system. A proposed generic ADR form provides detailed information for causality assessment and could serve as a basis for a standard global reporting form.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsHumansWorld Health OrganizationIndiaCanadaAustraliaUnited StatesSouth AfricaUnited Kingdom

Stichwörter der Autor:innen

Uppsala Monitoring Center (UMC)World Health Organization (WHO)adverse drug reactions (ADRs)pharmacovigilance

Autor:innen und Institutionen

  • Department of Pharmacology, Kalpana Chawla Government Medical College, Karnal, India.

Zitieren

APA

Misra, S., Kaur, M., & Kairi, J. K. (2025). A critical comparison of pharmacovigilance reporting forms in six countries with the WHO-UMC recommendations (form of the form). Journal of Basic and Clinical Physiology and Pharmacology. https://doi.org/10.1515/jbcpp-2025-0084

Vancouver

Misra S, Kaur M, Kairi JK. A critical comparison of pharmacovigilance reporting forms in six countries with the WHO-UMC recommendations (form of the form). Journal of Basic and Clinical Physiology and Pharmacology. 2025. doi:10.1515/jbcpp-2025-0084

BibTeX
@article{Misra2025,
  author = {Misra, Saurav and Kaur, Manmeet and Kairi, Jayant Kumar},
  title = {A critical comparison of pharmacovigilance reporting forms in six countries with the WHO-UMC recommendations (form of the form)},
  journal = {Journal of Basic and Clinical Physiology and Pharmacology},
  year = {2025},
  doi = {10.1515/jbcpp-2025-0084}
}
Kostenlos starten →